血管瘤发病机制的研究进展  

Investigative Progress of Pathogenesis of Hemangioma

作　　者：于涛[1] 高庆红[1] 温玉明[1] 

机构地区：[1]四川大学华西口腔医学院口腔颌面外科学教研室,四川成都610041

出　　处：《国际口腔医学杂志》2007年第2期122-124,共3页International Journal of Stomatology

摘　　要：血管瘤是婴幼儿常见的良性肿瘤,发病率高,危害性大。随着分子生物学的发展,学者们从细胞、细胞因子、基因、蛋白酶及其抑制剂、雌激素方面对血管瘤的发病机制进行了大量的探索。本文就该领域的研究进展作一综述。Hemangioma is a commonly benign tumour for infants and children. This tumor is characterized by high incidence and considerable detriment, Along with the development of molecular biology, many scholars have been researching the pathogenesis through cell, cell factor, gene, estrogen, protease and its inhibitor. This article reviews the investigative progression of this area.

关 键 词：血管瘤 发病机制 雌激素 

分 类 号：R732.2[医药卫生—肿瘤]